• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Ro Launches WebMd-Like Health Information Website

Share:

February 18, 2020

Direct-to-consumer virtual health company Ro launched a new health information platform dubbed Health Guide.

Currently the platform covers sexual health, hair loss, weight management, diabetes, and men’s health. However, a representative from the company said that in the future, the plan is to expand the offerings to not only cater to male users, and to include more conditions.

The company, which got its start in the men’s sexual health space, said that the new service is designed to compete with the likes of WebMD and Google searches.

“We created Health Guide to fulfill one of Roman’s guiding principles: to meet patients at eye level,” the Roman Health Guide team wrote on its welcome announcement. “We know the internet is already bursting with health-related content. But we also know that this material isn’t always complete, easy to understand, trustworthy, or fun to read. So we decided to do it better.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Users can access medical articles that give users insight into causes, symptoms, diagnoses and treatment options. The site will also have a lifestyle health component, which gives readers articles about new health findings that can impact daily life. Lastly the site has an ‘Ask the Expert’ section where doctors answer frequently asked questions. Doctors and surgeons from NYU Langone Health and Maimoides Medical Center are part of the editorial team creating the content.

The new editorial team is led by VICE alumni Grant Stoddard, whose his portfolio includes a variety of risqué men’s, sexual and cosmetic health stories. He has also been published in Men’s Health and the New York Magazine.

WHY IT MATTERS

Patients are increasingly turning to the internet to find out more about their health. An October survey released by ResMed found that six out of 10 consumers use the internet to try to diagnose themselves — and that number is higher for millennials (76%).

Additionally a new Aetna survey polling thousands of international office workers found that (43%) said they would investigate their condition online and then see a practitioner.

However, online medical advice has historically varied in reliability.

THE LARGER TREND

Although Ro started out in men’s health, it has since launched Rory, a platform for women experiencing menopause. It has also expanded to smoking cessation with its platform Zero, which uses a prescription nicotine replacement therapy and behavioral app. The company is also particularly well funded. In 2018 it landed $85 million to work on Zero.

It hasn’t been entirely smooth sailing for the company. Over the Summer Ro and its main competitor, Hims, which also works in in the online mail-order sexual health space, got heat when a New York Times article examined the company’s prescribing practices. The article points out that the clients come to the platforms with a “self-diagnosis” and don’t need to see a doctor in person.

Source: MobiHealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Clinical Trial Management Company ClinOne Scores $3.6MClinical Trial Management Company ClinOne Scores $3.6M
  • Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AGGowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG
  • The Advent Of AI And Blockchain In Health CareThe Advent Of AI And Blockchain In Health Care
  • How behavioural design is transforming the role and impact of life sciences in healthcareHow behavioural design is transforming the role and impact of life sciences in healthcare
  • ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar MedicalZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical
  • Foamix Announces Orbimed’s Support of Merger with Menlo TherapeuticsFoamix Announces Orbimed’s Support of Merger with Menlo Therapeutics
  • Renalytix AI Adds New Biomarkers to Platform for Tricky to Diagnose CKDRenalytix AI Adds New Biomarkers to Platform for Tricky to Diagnose CKD
  • SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney DiseaseSanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications